Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Particulate hexavalent chromium exposure induces DNA double-strand breaks and inhibits homologous recombination repair in rat and human lung tissues.

Chemosphere·2024
Same author

Surgical resection of micronodular thymic carcinoma with lymphoid hyperplasia: a case report.

General Thoracic and Cardiovascular Surgery Cases·2024
Same author

Impact of interstitial lung disease gender-age-physiology index in surgically treated lung cancer.

International journal of clinical oncology·2024
Same author

DNA methylation and mRNA expression of ZNF577 as biomarkers for the detection and prognosis of lung adenocarcinoma.

Oncology reports·2024
Same author

Symptomatic adverse events of chemotherapy in breast cancer patients:Using CTCAE, PRO-CTCAE, and EORTC QLQ-C30.

The journal of medical investigation : JMI·2024
Same author

Hexavalent chromium exposure activates the non-canonical nuclear factor kappa B pathway to promote immune checkpoint protein programmed death-ligand 1 expression and lung carcinogenesis.

Cancer letters·2024

Related Experiment Video

Updated: Jul 6, 2026

Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation
08:35

Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation

Published on: December 29, 2014

Optimal therapy for thymoma.

Kazuya Kondo1

  • 1Department of Adult and Gerontological Nursing, School of Health Sciences, The University of Tokushima, Tokushima, Japan.

The Journal of Medical Investigation : JMI
|March 6, 2008
PubMed
Summary

Thymoma, a common anterior mediastinum tumor, has optimal treatment dependent on clinical stage. Surgery is primary, with chemotherapy and radiotherapy showing high response rates, especially for advanced stages.

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Immunology

Background:

  • Thymoma is the most frequent tumor in the anterior mediastinum.
  • It is linked to distinct paraneoplastic syndromes, including myasthenia gravis and autoimmune disorders.
  • The rarity of thymoma has historically complicated treatment strategies.

Purpose of the Study:

  • To review the optimal treatment strategies for thymoma based on its clinical stage.
  • To discuss the role of the World Health Organization (WHO) classification in understanding thymoma.
  • To evaluate the efficacy of different therapeutic modalities.

Main Methods:

  • Review of existing literature on thymoma treatment.
  • Analysis of treatment outcomes based on clinical staging (WHO classification).

Related Experiment Videos

Last Updated: Jul 6, 2026

Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation
08:35

Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation

Published on: December 29, 2014

  • Evaluation of surgical, chemotherapeutic, and radiotherapeutic approaches.

    • Main Results:

    • Surgical resection is the primary treatment for all stages of thymoma.
    • Stage I thymoma is treated with surgical resection alone.
    • Multimodality therapy (surgery, chemotherapy, radiotherapy) improves outcomes for advanced stages (III and IV).

    Conclusions:

    • Optimal thymoma treatment is stage-dependent.
    • Surgery is the cornerstone of treatment for thymic epithelial tumors.
    • Combined modality treatment offers survival benefits for advanced thymoma.